title: Effect of synthetic oligopeptides on osteoporosis.
abstract: The objective of this study was to establish the solution method of GHRPS, the synthetic oligopeptides Tyr-Gly-Gly-Phe-Met-NH2, Tyr-Gly-Gly-Phe-Met-OH, Tyr-Gly-Gly-Phe-Leu-NH2, Tyr-Gly-Gly-Phe-Leu-OH, Tyr-Gly-Gly-Phe-Gly-NH2, and Tyr-Gly-Gly-Phe-Gly-OH, to verify their effect on osteoporosis. Male ICR mice (20 +/- 2 g) were used. The intramuscular injection dose of 6.3 mg/kg prednisone induced a significant decrease of body and femur weight of the animals. The subcutaneous injection dose of 18 microg/kg synthetic peptide was not effective to prevent the decrease of body and femur weight of the animals. The subcutaneous injection dose of 6.3 mg/kg prednisone elicited a decrease in content of femur calcium and in the level of serum calcium of the animals. The subcutaneous injection dose of 18 microg/kg Tyr-Gly-Gly-Phe-Leu-NH2, or Tyr-Gly-Gly-Phe-Leu-OH, or Tyr-Gly-Gly-Phe-Gly-NH2, significantly increased the content of femur calcium and decreased the level of serum calcium of the animals. It was also observed that the subcutaneous injection dose of 18 microg/kg Tyr-Gly-Gly-Phe-Gly-OH, Tyr-Gly-Gly-Phe-Leu-OH, Tyr-Gly-Gly-Phe-Met-OH, Tyr-Gly-Gly-Phe-Met-NH2 significantly increased the content of femur phosphorous and decreased the activity of ALP of the animals.
authors.affiliation: College of Pharmaceutical Sciences, Peking University, Beijing, P.R. China. CWein@mail.bjmu.cn
authors.forename: Cui
authors.initials: C
authors.lastname: Weina
authors.forename: Wang
authors.initials: W
authors.lastname: Chao
authors.forename: Zhao
authors.initials: Z
authors.lastname: Ming
authors.forename: Peng
authors.initials: P
authors.lastname: Shiqi
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001835:Body Weight; D002118:Calcium / Q000097:blood / Q000378:metabolism; D005269:Femur / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009842:Oligopeptides / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use*; D009929:Organ Size; D010024:Osteoporosis / Q000097:blood / Q000188:drug therapy*; D051381:Rats
chemical_list: D009842:Oligopeptides; D002118:Calcium